Due to the persistent abuse of potent stimulants and the related adverse social and individual consequences, the overall objective of this Program Project is to elucidate the mechanisms responsible for the effects of potent stimulants of abuse, such as methamphetamine (METH) and cocaine (COC). In particular, the prevailing hypothesis to be tested by projects in this revised application is that METH and COC administration exert significantly different effects due to their distinct neurochemical mechanisms particularly to transporters and associated functions. We believe that by elucidating (a) the unique features of these two drugs, (b) their underlying mechanisms, and (c) the impact of their distinct properties, and other stimulants. The distinctive expertise at the University of Utah associated with the (a) Addiction Research and Education Center, (b) Anticonvulsant Screening Project, and (c) Center for Human Toxicology, enables to identify four principal projects that will test the overall hypothesis in a highly integrative fashion. The titles of the projects and their objectives are: i. Tolerance Induction (Project #1)-This project will determine the nature of the tolerance caused by escalating doses of METH, but not COC, and the effecting mechanism. ii. VMAT and Neurotoxicity (Project #2)-This project will determine how the opposite effects of METH and CC on VMAT contributes to the presence or absence of neurotoxicity. iii. Neuropeptides and Neurotoxicity (Project #3)-This project will examine the role of differential response by opioid peptide systems to METH and COC on the unique neurotoxic features of these stimulants. iv. Seizure Induction (Project #4)-This project will determine the unique features of seizures evoked by high doses of METH and COC and the underlying mechanisms. In a supportive role, the Administrative Core will function as the principal decision-making, evaluative, and administrative unit for this program; while the Resource Core will enhance efficiency and quality, and reduce expenses by providing high-quality, centralized animal and technology services for the project.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (06))
Program Officer
Lin, Geraline
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Schools of Pharmacy
Salt Lake City
United States
Zip Code
German, Christopher L; Gudheti, Manasa V; Fleckenstein, Annette E et al. (2017) Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy. Methods Mol Biol 1663:153-162
Baladi, Michelle G; Nielsen, Shannon M; McIntosh, J Michael et al. (2016) Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol 27:422-30
Fricks-Gleason, Ashley N; German, Christopher L; Hoonakker, Amanda J et al. (2016) An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse 70:139-46
German, Christopher L; Baladi, Michelle G; McFadden, Lisa M et al. (2015) Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev 67:1005-24
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. J Pharmacol Exp Ther 355:463-72
Alburges, Mario E; Hoonakker, Amanda J; Cordova, Nathaniel M et al. (2015) Effect of low doses of methamphetamine on rat limbic-related neurotensin systems. Synapse 69:396-404
Vieira-Brock, Paula L; McFadden, Lisa M; Nielsen, Shannon M et al. (2015) Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol 18:
McFadden, Lisa M; Vieira-Brock, Paula L; Hanson, Glen R et al. (2015) Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology 93:146-54
German, Christopher L; Fleckenstein, Annette E; Hanson, Glen R (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci 97:2-8
Baladi, Michelle G; Nielsen, Shannon M; Umpierre, Anthony et al. (2014) Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats. Behav Pharmacol 25:758-65

Showing the most recent 10 out of 73 publications